{"title":"干细胞和心脏:伦理、组织和资金。","authors":"John F Martin","doi":"10.1038/ncpcardio0445","DOIUrl":null,"url":null,"abstract":"<p><p>The application of stem cell biology to repair of the heart offers therapeutic potential. However, randomized, double-blind, controlled trials are required to clarify under what conditions it may be effective. The unprecedented nature of the discovery of a therapeutic role for autologous stem cells brings with it unprecedented challenges in clinical application of basic biology, ethics, funding and organization. It is suggested that the academic community should show leadership.</p>","PeriodicalId":51263,"journal":{"name":"Nature Clinical Practice. Cardiovascular Medicine","volume":"3 Suppl 1 ","pages":"S136-7"},"PeriodicalIF":0.0000,"publicationDate":"2006-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/ncpcardio0445","citationCount":"0","resultStr":"{\"title\":\"Stem cells and the heart: ethics, organization and funding.\",\"authors\":\"John F Martin\",\"doi\":\"10.1038/ncpcardio0445\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The application of stem cell biology to repair of the heart offers therapeutic potential. However, randomized, double-blind, controlled trials are required to clarify under what conditions it may be effective. The unprecedented nature of the discovery of a therapeutic role for autologous stem cells brings with it unprecedented challenges in clinical application of basic biology, ethics, funding and organization. It is suggested that the academic community should show leadership.</p>\",\"PeriodicalId\":51263,\"journal\":{\"name\":\"Nature Clinical Practice. Cardiovascular Medicine\",\"volume\":\"3 Suppl 1 \",\"pages\":\"S136-7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1038/ncpcardio0445\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Clinical Practice. Cardiovascular Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1038/ncpcardio0445\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Clinical Practice. Cardiovascular Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1038/ncpcardio0445","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Stem cells and the heart: ethics, organization and funding.
The application of stem cell biology to repair of the heart offers therapeutic potential. However, randomized, double-blind, controlled trials are required to clarify under what conditions it may be effective. The unprecedented nature of the discovery of a therapeutic role for autologous stem cells brings with it unprecedented challenges in clinical application of basic biology, ethics, funding and organization. It is suggested that the academic community should show leadership.